Skip to main content
Value Investing

Stock Valuation for Beginners: 5 Methods to Find Intrinsic Value

Javier Sanz, Founder & Lead Analyst at ValueMarkers
By , Founder & Lead AnalystEditorially reviewed
Last updated: Reviewed by: Javier Sanz
12 min read
Share:

Stock Valuation for Beginners: 5 Methods to Find Intrinsic Value

Here is a fact that many new investors learn the hard way: you can own a great business and still lose money. If you pay too much for Amazon, Apple, or any other high-quality company, you can hold it for years and underperform the market -- or lose money outright. This is not a hypothetical. Investors who bought Cisco at the peak of the dot-com bubble in 2000 waited more than 20 years to break even, despite Cisco being a real, profitable, dominant technology company the entire time.

The price you pay relative to value is the single most important variable in long-term investment outcomes. That is what stock valuation is: the systematic attempt to estimate what a business is worth -- its intrinsic value -- so you can compare that estimate to the current market price and decide whether you are getting a good deal, a fair deal, or an overpriced one.

This guide explains five core valuation methods from first principles, with worked examples for each.

This article is for educational purposes only and does not constitute financial advice.

Why Valuation Matters: The Overpaying Problem

Think of buying a stock as buying a fraction of a business. If you buy 1% of a business that generates $1 million in annual profit, a reasonable price for that stake depends on how confident you are in those earnings, how much they are likely to grow, and what alternatives you have for your capital.

Pay $100,000 for that 1% stake and you are getting a 10x earnings multiple -- probably a good deal if the business is stable. Pay $500,000 and you are at 50x earnings -- you need extraordinary growth to justify that price. Pay $1,000,000 and you are at 100x earnings -- you need near-perfect execution of an aggressive growth scenario, and any disappointment will be punished severely.

The market price of a stock is what someone is willing to pay right now. Intrinsic value is what the business is actually worth based on what it will generate over its life. Sometimes these are close. Sometimes they diverge dramatically -- in either direction. Valuation is the process of estimating intrinsic value so you can recognize the difference.

Method 1: The P/E Ratio Method

The concept: The price-to-earnings ratio is the most widely used valuation metric in equity markets. It tells you how many years of current earnings you are paying for at the current price.

The formula:

  • Intrinsic Value Estimate = Normalized EPS × Appropriate P/E Multiple

Step-by-step example:

Suppose a company earns $4.00 per share in a typical year (normalized for any one-time items). You determine that comparable businesses in the same industry trade at 15-18x earnings, and this company has average growth prospects and modest competitive advantages.

  • Normalized EPS: $4.00
  • Appropriate P/E range: 14-16x (slightly below peers given average quality)
  • Intrinsic Value Estimate: $4.00 × 15 = $60 per share

If the stock is trading at $45, you have a potential 25% margin of safety. If it is trading at $72, you are paying a 20% premium to your estimate of fair value.

When to use it: Quick screening, mature businesses with stable earnings, consumer staples, utilities, established industrials. The P/E method works well when earnings are predictable and not distorted by one-time items.

When NOT to use it:

  • Companies with volatile or cyclical earnings (use normalized earnings, not trailing)
  • Companies with negative earnings (the ratio is undefined)
  • High-growth companies where near-term P/E is very high but growth justifies it
  • Financial companies (P/E is less relevant; use P/TBV and ROE instead)
  • Companies with significant non-cash charges that distort reported earnings

Key pitfall: Never use trailing earnings that include unusual one-time items. If a company had a one-time gain that inflated earnings, the trailing P/E looks cheap but the normalized P/E is much higher. Always use normalized, mid-cycle earnings for this method.

Method 2: The DCF Method

The concept: Discounted Cash Flow is the most theoretically rigorous valuation method. It directly addresses the fundamental question: what is the present value of all the cash flows this business will generate in the future?

The formula:

  • Intrinsic Value = Sum of (Free Cash Flow_t / (1 + WACC)^t) for t = 1 to N, plus Terminal Value / (1 + WACC)^N

Step-by-step example:

Suppose a company generates $100 million in free cash flow this year. You project 10% annual FCF growth for years 1-5 and 5% growth for years 6-10, then a 3% perpetual growth rate in the terminal period. WACC is 9%.

Year 1 FCF: $110M, discounted at 9% = $100.9M Year 2 FCF: $121M, discounted = $101.9M ... (continue for 10 years)

Year 10 FCF: $235M Terminal Value = $235M × (1.03) / (0.09 - 0.03) = $4,035M PV of Terminal Value = $4,035M / (1.09)^10 = $1,704M

Sum of discounted FCFs for years 1-10 ≈ $800M Add Terminal Value PV: $1,704M Enterprise Value: $2,504M

Subtract net debt and divide by shares outstanding to get equity value per share.

If the company has 50 million shares and $200M net debt: Equity Value = ($2,504M - $200M) / 50M = $46.08 per share

When to use it: Any business with reasonably predictable cash flows. The DCF is most powerful for mature technology, consumer brands, industrial companies, and subscription businesses. It forces you to be explicit about your assumptions.

When NOT to use it:

  • Pre-revenue or very early-stage companies with no visible path to profitability
  • Highly cyclical businesses where cash flows vary dramatically (the assumptions will dominate the output)
  • Financial companies (use different cash flow definitions)
  • As a standalone method without sensitivity analysis -- a DCF without stress testing is false precision

Key pitfall: The terminal value dominates the output -- often 60-80% of the total value. A small change in terminal growth rate assumption has enormous effects. Always run sensitivity tables: vary WACC by ±1-2% and terminal growth by ±1%, and assess whether the range of outputs is consistent with your thesis.

ValueMarkers' DCF calculator handles this automatically, letting you adjust WACC, growth rates, and margins to see how intrinsic value changes with your assumptions.

Method 3: The Graham Number

The concept: The Graham Number is Benjamin Graham's quick formula that simultaneously enforces two constraints: a P/E ratio no higher than 15 and a P/B ratio no higher than 1.5. It is the geometric mean of these two metrics applied to EPS and book value per share.

The formula:

  • Graham Number = √(22.5 × EPS × BVPS)

The 22.5 comes from 15 × 1.5 = 22.5 (the product of the P/E and P/B limits).

Step-by-step example:

A company reports:

Graham Number = √(22.5 × $3.50 × $28.00) = √(22.5 × $98.00) = √($2,205) = $46.96 per share

This tells you that Graham's formula considers $46.96 to be the maximum price a conservative investor should pay. If the stock is below $46.96, it passes Graham's two primary quantitative filters. If it is above, Graham would typically look elsewhere.

When to use it: Quick screening across large universes of stocks, especially for defensive stock selection. Particularly useful for asset-heavy businesses, financials, and industrials where both P/E and P/B are meaningful.

When NOT to use it:

  • Technology, software, and knowledge-economy companies where P/B is irrelevant (book value understates economic value)
  • Companies with negative earnings (formula cannot be computed)
  • Growth companies where a P/E of 15 is too restrictive
  • As a precise intrinsic value estimate -- it is a screening tool, not a valuation model

Key pitfall: The Graham Number will almost always return a "too expensive" verdict for excellent businesses with durable competitive advantages, because those businesses command P/B multiples well above 1.5. A stock failing the Graham Number is not necessarily overvalued -- it may simply be a quality business that Graham's conservative asset-focused framework was not designed for.

ValueMarkers computes the Graham Number for every company in its database, making it immediately usable as a first-pass screen alongside other metrics.

Method 4: EV/EBITDA Comparable Company Method

The concept: Enterprise Value / EBITDA is a multiple-based valuation method that compares a company to its peers. EV captures the total value of the business (equity plus net debt), and EBITDA is a proxy for operating cash generation before financing and accounting choices. Comparing EV/EBITDA across peers reveals whether a company trades at a discount or premium to the industry.

The formula:

  • Intrinsic Value Estimate = Industry Median EV/EBITDA × Company EBITDA - Net Debt

Step-by-step example:

You are analyzing a mid-sized industrial manufacturer. Its EBITDA is $80 million and net debt is $150 million. Comparable companies trade at EV/EBITDA multiples ranging from 8x to 12x, with a median of 9.5x.

  • Estimated Enterprise Value = 9.5 × $80M = $760M
  • Equity Value = $760M - $150M = $610M
  • If 20 million shares outstanding: Equity Value per Share = $30.50

If the stock is trading at $22, it is at a 28% discount to comparable company value -- potentially attractive.

When to use it:

  • Comparing companies within the same industry where peers are clearly identified
  • Capital-intensive businesses where depreciation is large and non-cash (EV/EBIT overstates the multiple)
  • Leveraged buyout analysis (private equity uses EV/EBITDA extensively)
  • Cross-company comparisons when capital structures differ (EV neutralizes leverage)
  • M&A analysis (transaction multiples are routinely expressed as EV/EBITDA)

When NOT to use it:

  • Financial companies (banks, insurance: EBITDA is not a meaningful concept)
  • Real estate companies (use price/FFO or NAV)
  • As a substitute for DCF when growth rates differ significantly across peers -- a high-growth company will naturally command a higher EV/EBITDA
  • When there are no genuinely comparable public companies

Key pitfall: The comparables method anchors your valuation to the market's current pricing of the sector. If the entire sector is overvalued, comparables will point to an overvalued result. This method tells you relative value (cheap vs expensive vs peers), not absolute value. Always supplement with a DCF to anchor to fundamentals.

Method 5: Asset-Based Valuation

The concept: Asset-based valuation estimates intrinsic value from the balance sheet -- specifically, from what the assets could be sold for in an orderly liquidation. It is the most conservative approach and the one most directly aligned with Graham's original framework.

There are two primary versions:

Book Value Method:

  • Equity Value = Total Assets - Total Liabilities = Shareholders' Equity
  • Value per Share = Shareholders' Equity / Shares Outstanding

Net Current Asset Value (NCAV) -- the more conservative version:

  • NCAV = Current Assets - Total Liabilities (all liabilities)
  • A stock trading below NCAV is trading below its liquidation value of current assets alone, with fixed assets thrown in for free

Step-by-step example:

A manufacturing company has:

  • Current Assets: $180M (cash $40M, receivables $80M, inventory $60M)
  • Fixed Assets (PP&E): $120M
  • Total Assets: $300M
  • Current Liabilities: $60M
  • Long-Term Debt: $80M
  • Total Liabilities: $140M
  • Shareholders' Equity (Book Value): $160M

NCAV = $180M (current assets) - $140M (all liabilities) = $40M Book Value: $160M

If the company has 10 million shares:

  • Book Value per Share: $16.00
  • NCAV per Share: $4.00

A stock at $11.00 is below book value (P/B = 0.69) but above NCAV. This is a classic deep-value situation -- cheap on assets but not at the most extreme Graham level.

When to use it:

  • Businesses in distress or facing bankruptcy consideration
  • Asset-heavy industries (manufacturing, real estate, shipping)
  • Holding companies with clear asset values
  • Banks and financial institutions (use tangible book value)
  • As a floor estimate to complement earnings-based methods

When NOT to use it:

  • Software, technology, and service businesses where assets are thin but earnings power is high
  • Growing businesses where the present value of future earnings far exceeds current asset value
  • Companies with largely intangible assets (brands, patents, algorithms) that are not on the balance sheet
  • As a standalone method for any business that earns returns well above its cost of capital

Key pitfall: Book value includes goodwill from acquisitions, which is often worthless or impaired. Always calculate tangible book value (subtract goodwill and intangibles) for a more conservative floor. NCAV is even more conservative because it also strips out fixed assets.

How to Combine Methods: The Composite Approach

Each of the five methods has a different perspective on value:

  • P/E captures earnings power relative to price
  • DCF captures the discounted present value of future cash generation
  • Graham Number enforces both an earnings and an asset-value constraint simultaneously
  • EV/EBITDA provides market context through comparable company pricing
  • Asset-Based establishes a floor based on what the balance sheet contains

No single method should be used in isolation. A business might look cheap on P/E but expensive on DCF if its earnings are unsustainably high. It might look cheap on Graham Number but have a deteriorating balance sheet that asset-based analysis reveals. Convergence across methods is much more powerful than any single metric.

Professional value investors typically build a "valuation range" -- using multiple methods to establish a low estimate, a base estimate, and an optimistic estimate. If the current stock price is below all three, the investment is compelling. If it is above all three, it should be avoided. When price falls between the low and base estimate, the investment requires a judgment about which scenario is more likely.

ValueMarkers takes exactly this composite approach. Its intrinsic value analysis combines a multi-stage DCF, Graham Number computation, and balance sheet floor analysis into a single dashboard, highlighting where the current price falls relative to each estimate and what growth assumptions the market is implicitly pricing in.

Building a Simple Valuation Process

For a beginning investor, here is a practical sequence:

  1. Start with the Graham Number as a quick screen. If the stock is well above the Graham Number, it is either a high-quality business that requires DCF justification or genuinely overpriced.

  2. Check EV/EBITDA vs peers to understand where the company trades relative to its industry. Is the discount to peers explained by lower quality, or is it a genuine mispricing?

  3. Build or review a DCF with explicit growth and margin assumptions. What would the business need to do over the next 10 years to justify the current price? Is that realistic?

  4. Assess asset value via tangible book value as a floor. How much protection do you have if earnings deteriorate significantly?

  5. Calculate your margin of safety. What is the gap between your best estimate of intrinsic value and the current price? Is it sufficient given the uncertainty in your analysis?

  6. Make the decision. If multiple methods point to undervaluation, the margin of safety is adequate, and the business quality is sufficient, you have a rational basis for investment. If they diverge, understand why before committing.

The Bottom Line

Stock valuation is not a formula that spits out a precise answer. It is a process for organizing your thinking about what a business is worth and comparing that to what the market is charging. Every method involves assumptions, and every assumption contains uncertainty.

What valuation discipline gives you is not certainty -- it is a framework for avoiding the worst outcome: paying dramatically more for a business than it is worth and watching the price revert toward fundamental value over years.

The five methods covered here -- P/E, DCF, Graham Number, EV/EBITDA, and asset-based -- each capture a different dimension of value. Used together, with explicit attention to their limitations and contexts, they constitute the core toolkit of fundamental equity analysis. Start with the simplest screen, build toward the full DCF model, and always ask: at this price, what do I need to believe about this business's future to get my money back with an adequate return?

That question, asked rigorously and honestly, is the beginning of sound investing.

Explore More

Investing Tools

Compare Competitors

Browse Stocks

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.